Peripubertal changes in circulating antimüllerian hormone levels in girls  by Lashen, Hany et al.
ORIGINAL ARTICLES: REPRODUCTIVE ENDOCRINOLOGYPeripubertal changes in circulating
antim€ullerian hormone levels in girls
Hany Lashen, F.R.C.O.G.,a David B. Dunger, M.D.,b Andy Ness, Ph.D.,c and Ken K. Ong, Ph.D.b,d
a Reproductive and Developmental Medicine Unit, University of Shefﬁeld, Shefﬁeld; b Department of Paediatrics and
Institute of Metabolic Science, University of Cambridge, Cambridge; c School of Oral and Dental Sciences, University of
Bristol, Bristol; and d Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Cambridge, United
KingdomObjective: To identify correlates and longitudinal changes in circulating antim€ullerian hormone (AMH) levels as a marker of ovarian
primordial follicle recruitment in normal peripubertal girls.
Design: Observational study using mixed longitudinal and cross-sectional analyses.
Setting: Not applicable.
Patient(s): Unselected girls assessed at ages 7–11 years.
Intervention(s): None.
Main Outcome Measure(s): AMH, inhibin B, and FSH levels were analyzed in blood samples collected at ages 7, 9, and 11 years for
longitudinal analyses and at age 8 years for cross-sectional analyses.
Result(s): In the cross-sectional analysis, AMH levels at age 8 years were lower in pubertal girls (median 25.0 pmol/L, interquartile
range [IQR] 16.0–33.9; n ¼ 39) than in prepubertal girls (33.5 pmol/L, IQR 22.3–49.1; n ¼ 342). In prepubertal girls, higher AMH
levels were associated with higher inhibin B levels, lower FSH levels, and larger body mass index at age 8 years and subsequently
with later age at menarche. AMH levels were unrelated to birth weight or birth length. In the longitudinal analysis, AMH levels
increased between ages 7 (median 27.0 pmol/L, IQR 19.2–34) and 9 years (32.0 pmol/L, IQR 26.5–42.7), then declined between 9
and 11 years (26.5 pmol/L, IQR 19–42.25) with high intraindividual correlation in AMH levels between ages 7 and 9 years and 7
and 11 years.Use your smartphoneConclusion(s): Measurement of circulating AMH and inhibin B levels suggests that the rate of
ovarian primordial follicle recruitment increases in the prepubertal years then declines again
following the onset of puberty as follicular activity pattern changes. (Fertil Steril 2013;99:
2071–5. 2013 by American Society for Reproductive Medicine.)
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scanner” in your smartphone’s app store or app marketplace.T he dimeric glycoprotein anti-m€ullerian hormone (AMH) isproduced from the granulosa
cells of developing preantral and small
antral ovarian follicles and may act to
provide feedback inhibition of follicle
development at two levels: ﬁrst, by in-
hibiting the recruitment of further pri-
mordial follicles into the growing
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High levels of AMH were reported in
the follicular ﬂuid of small antral folli-
cles, and signiﬁcantly reduced levels
were reported in preovulatory follicles
(2), suggesting that the production of
AMH is independent from the granu-
losa cell number and more likely re-
ﬂects the number of early antral
follicles. Circulating AMH levels areary 25, 2013; published online February 15, 2013.
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/j.fertnstert.2013.01.139considered to be a reliable marker of
the rate of recruitment of primordial
follicles into the growing pool, which
in turn reﬂects the size of the ovarian
reserve of primordial follicles. Accord-
ingly, in adult women, AMH levels de-
cline steadily with age and are highly
predictive of age at menopause (3). In-
hibin B also is secreted from preantral
and small antral ovarian follicles, but,
unlike AMH, inhibin B secretion is
stimulated by FSH and its circulating
levels therefore reﬂect both the number
and the pituitary-stimulated activity of
early developing follicles (4).
In children, circulating AMH levels
during childhood and adolescence have
recently been described in longitudinal
and cross-sectional studies (5–7). These
studies reported that AMH levels are2071
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continues during the years leading up to puberty, roughly
doubling between ages 4 and 8 years and then reaching
a plateau during adolescence. The observed steady decline
in AMH levels during adulthood is consistent with the
dogma that a girl’s ovarian reserve of primordial follicles is
established in utero and soon after birth (8) and then
declines progressively until she reaches menopause (9–11).
Mathematical models based on histologic studies have
suggested that the highest rate of recruitment of
nongrowing follicles takes place between birth and 14 years
of age (11), which is synchronous with menarche in the
majority of girls. However the number of subjects under the
age of 14 included in that study was too small to establish
what actually took place in early childhood compared with
the prepubertal years. Nevertheless, the reported marked
increase in AMH levels (5–7) during early childhood
conﬁrms to some extent the Wallace and Kelsey (11)
ﬁndings that may indicate a process of up-regulation of
such activity in the years leading up to the onset of puberty.
Although cross-sectional studies infer that AMH levels are
stable between ages 8 with 25 years and then gradually decline
with age (5, 6), more detailed longitudinal studies have revealed
a 30% reduction in AMH levels during the ﬁrst 2 years after
pubertal onset (12), indicating the possible regulation of AMH
production during puberty. In consideration of the potential
factors that might regulate AMH production during childhood,
studies have related AMH levels in children and adults to
certain growth characteristics, although the ﬁndings are
inconsistent. Early small studies suggested that AMH levels
were higher in infants following low birthweight (BW) or high
BW, compared with normal BW, suggesting antenatal altered
follicular development (13). However, recent larger studies
found no differences in AMH levels in prepubertal girls or
young women according to birthweight or gestational age (14,
15). Furthermore, growth hormone treatment had no effect on
AMH levels. In adults, lower AMH levels in obese versus
normal weight has been reported in some (16, 17) but not all
(18) studies. However, such relationships may be obscured by
the higher AMH levels that are consistently observed in
women with polycystic ovary syndrome (PCOS), as well as in
their ﬁrst-degree relatives, even during childhood (19, 20).
In a large sample of normal girls, we aimed to identify the
hormonal and growth-related correlates of the rate of ovarian
primordial follicle recruitment during peripuberty at age 8
years with the use of AMH as a marker of such activity. Fur-
thermore, in a longitudinal study on a smaller number of sub-
jects, we explored the temporal changes and degree of
intraindividual tracking in AMH levels (as a marker of follic-
ular recruitment activity) and inhibin B levels (as a marker of
follicular development activity) in the peripubertal years.MATERIALS AND METHODS
Population
The Avon Longitudinal Study of Parents and Children (AL-
SPAC) is a prospective cohort recruited from all pregnancies
in three Bristol-based District Health Authorities in the United
Kingdom with expected dates of delivery from April 1991 to2072December 1992. Out of the initial 14,541 pregnant mothers
who enrolled in the ALSPAC study, there were 14,062 live
births and 13,988 infants alive at 1 year. Details of antenatal
data collection and measurement of body size from birth to 5
years by the ALSPAC study team is available at
www.alspac.bristol.ac.uk.
Serum samples were available at age 8 years in 381 full-
term (gestational ageR37weeks) singleton girls from a previ-
ous study in a random ALSPAC subsample (21, 22). Samples
were collected in the morning after an overnight fast. In
addition, the whole cohort was invited to provide venous
blood samples at ages 7, 9, and 11 years, following
application of a topical anesthetic cream. For the pilot
longitudinal study, 32 girls who had serum samples
available at all three ages (7, 9, and 11 years) were
randomly (the samples from the ﬁrst 32 girls in the
database) chosen from the last 6 months of ALSPAC full-
term births.
Fat mass at mean age 9.9 years was measured using a Lu-
nar Prodigy Dual-energy X-ray absorptiometry scanner (GE
Medical Systems Lunar). Scans were visually inspected and
realigned where necessary. Analyses that included fat mass
also included height and height-squared as covariables to en-
sure adjustment for greater relative adiposity, rather than
greater fat mass as a result of greater height. Height was mea-
sured to the nearest 0.1 cm with a Harpenden stadiometer
with the participant unshod.
Self-assessment of pubertal development was obtained
from the girls at age 8 years. Respondents were asked to exam-
ine line drawings and accompanying descriptions of the ﬁve
Tanner stages for breast size and pubic hair and to recordwhich
drawing most closely resembled their stage of development
The diagrams used were previously validated (correlation
with physician assessments were 0.63 for breast development,
and 0.81 for pubic hair distribution) (23). Girl’s age atmenarche
was assessed by questionnaire at ages 11 and 13 years and cat-
egorized into three groups:<12 years (n¼ 65), 12–13 years (n
¼ 74), and >13 years or ‘‘not yet’’ (n ¼ 174).
Ethical approval was obtained from the ALSPAC Law and
Ethics Committee and the local Research Ethics Committees.
Signed consent for before-breakfast study was obtained
from a parent or guardian, and verbal assent was obtained
from each of the children.Hormone Assays
AMHwas assayed in serum samples with the use of ELISA Im-
munotech). The sensitivity was 0.7 pmol/L (1 ng/mL ¼ 7.14
pmol/L). The manufacturer’s intra-assay coefﬁcient of varia-
tion (CV) based on samples assayed 12 times was %12.3%,
and interassay CV based on samples assayed in duplicate in
11 different series was <14.2%.
FSH was assayed with the use of electrochemilumines-
cence immunoassay designed for use on an Elecys and Cobas
immunoassay analyzer (Roche Diagnostics). The assay range
was 0.1–200 IU/L, and the CV was 4.5%.
Inhibin B was assayed with the use of Gen II ELISA (Im-
munotech) on a Beckman Coulter analyzer. The sensitivity
was 2.6 pg/mL and the CVs 4.4%–6.8%.VOL. 99 NO. 7 / JUNE 2013
FIGURE 1
Antim€ullerian hormone (AMH) levels at age 8 years in pubertal girls
(median 25.0 pmol/L, interquartile range [IQR] 16.0–33.9; n ¼ 39)
and prepubertal girls (33.5 pmol/L, IQR 22.3–49.1; n ¼ 342).
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TABLE 1
Median values and cross-sectional associations with antim€ullerian




Weight (kg) 27, 25–31 0.10 .07 341
Height (cm) 130, 126–133.5 0.02 .8 341
BMI (kg/m2) 16.3, 15.2–17.6 0.12* .03 341
Fat mass index
(at age 9 y)
4.3, 3.2–5.8 0.12* .04 316
Leptin (ng/mL)a 4.9, 3.3–8.0 0.12* .02 341
Insulin (mU/L)a 5.2, 3.4–8.1 0.03 .6 341
DHEAS (mcg/dL)a 16.9, 10.1–33.7 0.02 .7 298
Androstenedione
(ng/dL)a
53.4, 36.9–71.1 0.03 .4 297
IGF-I (ng/mL) 150, 117.3–181 0.09 .3 164
FSH (IU/L) 1.2, 0.8–1.7 0.32** < .0001 339
Inhibin B (pg/mL) 15.1, 9.3–24.9 0.41** < .0001 339




a These variables showed positively skewed distributions; therefore, correlations were ana-
lyzed on log-transformed values.
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Fertility and Sterility®LH levels were below the limit of detection (0.1 IU/L) in
the ﬁrst 100 samples and were therefore not analyzed in fur-
ther samples.
Information on the following hormone levels in the same
samples collected at age 8 years were available from previous
projects: IGF-1, insulin, DHEAS, androstenedione, and leptin
(22, 24).
Statistical Analysis
AMH levels at age 8 years showed a positive skewed distribu-
tion and were log-transformed to allow use of parametric
tests. Multivariate linear regression was used to test the corre-
lations between AMH levels at age 8 years and body size and
hormone levels (FSH and inhibin B) at age 8 years. Adjust-
ments were made for the child’s age at the 8 year clinic visit
by entering age as a covariable. Results are displayed as betas
(partial standardized correlation coefﬁcient).
For the pilot longitudinal study, we used paired t tests to
compare AMH levels between ages 7 and 9 years and between
ages 9 and 11 years. Pearson correlation was used to analyze
the correlation between AMH levels at the different ages.
RESULTS
Cross-Sectional Associations at Age 8 Years
In 381 girls at age 8 years (median age 8.2, range 8.0–8.5), me-
dian AMH levels were lower in the 39 girls with self-reported
pubertal breast development (25.0 pmol/L, interquartile range
[IQR] 16.0–33.9) than in 342 prepubertal girls (33.5 pmol/L,
IQR 22.3–49.1; P< .0001; Fig. 1).
Within prepubertal girls, higher AMH levels were also as-
sociated with: higher inhibin B levels, lower FSH levels, and
lower BMI at age 8 years; with lower fat mass index at 9 years
(Table 1); and with subsequent later age at menarche (P¼ .03).VOL. 99 NO. 7 / JUNE 2013AMH levels at age 8 years were unrelated to birth weight or
gestational age (P>.4; data not shown).
Five (1.3%) of 381 girls (three prepubertal) had very low
AMH levels of <8 pmol/L, which is the cutoff used to identify
ovarian failure in girls with Turner syndrome (25). These ﬁve
girls alsohad lower levels of inhibinB (median5.9pmol/L, range
2.8–7.4) compared with other girls (median 14.7 pmol/L, IQR
9.4–23.9), but no differences in FSH levels (data not shown).
Pilot Longitudinal Study
In 32 girls with longitudinal data, AMH levels rose between
ages 7 years (median 27.0 pmol/L, IQR 19.2–34) and 9 years
(32.0, IQR 26.5–42.7; paired t test:P< .0001), and then declined
by a similar amount up to age 11 years (26.5, IQR 19–42.25;
P¼ .003; Fig. 2). Despite these changes, there was strong intra-
individual tracking in AMH levels, both between 7 and 9 years
(Pearson coefﬁcient: r¼ 0.81; P< .001) and between 9 and 11
years (r¼ 0.73;P< .001). In contrast, inhibin B levels increased
continuously from ages 7 years (median 27.5 pg/mL, IQR 21.0–
36.2) to 9 years (41.0, IQR 31.0–59.5; paired t test:P¼ .002) and
11 years (72.5, IQR 46.5–126.0; paired t test: P¼ .0007), but
showed little intraindividual tracking between 7 and 9 years
(r ¼ 0.26; P¼ .2) or between 9 and 11 years (r ¼ 0.13; P¼ .5).
Baseline inhibin B levels at age 7 years were positively as-
sociated with early changes in AMH between 7 and 9 years
(correlation coefﬁcient ¼ 0.45; P¼ .01) and inversely associ-
ated with later changes in AMH between 9 and 11 years
(r ¼ 0.52; P¼ .003).
DISCUSSION
Wemeasured circulating AMH levels as a marker of the rate of
recruitment of primordial follicles. Our ﬁndings of complex
changes in, and cross-sectional associations with, AMH levels
indicate intriguing changes in the rate of ovarian follicle2073
FIGURE 2
Longitudinal changes in circulating (A) antim€ullerian hormone (AMH)
levels and (B) inhibin B levels, between ages 7, 9, and 11 years old in
32 girls. Each line represents an individual girl.
Lashen. Peripubertal AMH levels in girls. Fertil Steril 2013.
ORIGINAL ARTICLE: REPRODUCTIVE ENDOCRINOLOGYrecruitment during the peripubertal years, which correspond
to the timing of menarche.Prepubertal Rise in AMH Levels
Our observation of a longitudinal 20% rise in AMH levels dur-
ing the 2 years between ages 7 and9 years is consistentwith the
inferred doubling in AMH levels between ages 4 and 8 years in
cross-sectional data (5–7). Together, these ﬁndings suggest
that the rate of recruitment of ‘‘quiescent’’ primordial follicles
into ‘‘active’’ preantral follicles that produce AMH is not
a constant, nor simply a function of primordial follicle
numbers, but rather increases steadily as girls approach the
onset of puberty. This conclusion is consistent with a recent
review and analysis of cross-sectional data on primordial fol-
licle numbers from autopsy samples, which estimated that the
rate of follicle recruitment increases with age during child-
hood, despite declining total primordial follicle numbers (7).
The longstanding concept that the pituitary-gonadal axis
is inactive from late infancy until the abrupt reawakening of
pituitary sensitivity to GnRH has been questioned in recent2074years, with studies reporting gradual rises in the levels of E2
and inhibin B during the prepubertal years (25). It is not pos-
sible to say whether a gradual increase in ovarian follicle ac-
tivity facilitates or even triggers the onset of puberty, but the
concept is plausible.Reduction in AMH Levels with Puberty
Our cross-sectional ﬁnding that AMH levels were25% lower
in pubertal compared to prepubertal girls is consistent with our
pilot longitudinal data showing a 20% reduction in AMH levels
between ages 9 and 11 years, and conﬁrms other recent longi-
tudinal data (12). The onset of puberty is characterized in the
ovary by the progression of small antral follicles to antral fol-
licles, which do not produce AMH (1), and this could contribute
to the reduction in circulating AMH levels. Furthermore, Kelsey
et al. recently estimated that the rate of primordial follicle re-
cruitment peaks during adolescence and then declines (7); our
ﬁndings reﬁne the timing of such decline in follicle recruitment
to the onset of puberty. In contrast to AMH, inhibin B levels in-
creased by 49% between ages 7 and 9 years and increased by
a further 76% between ages 9 and 11 years. We consider that
the divergence between AMH and inhibin B levels beyond
age 9 years reﬂects the falling rate of primordial follicle recruit-
ment as FSH-stimulated follicle activity increaseswithmatura-
tion of the pituitary-gonadal axis.
Associations between AMH levels at 8 years and age at
menarche, and between baseline inhibin B levels and later
changes in AMH, suggest that prepubertal ovarian follicle ac-
tivity may predict the timing of pubertal onset and comple-
tion. However, this needs to be conﬁrmed in larger
longitudinal studies, ideally with the use of objective assess-
ments of pubertal timing. Longer follow-up is needed also to
show whether the close intraindividual tracking in AMH
levels during adolescence continues into adult life.Other Associations
We detected other associations—between lower circulating
AMH levels and higher BMI, higher leptin levels, and earlier
timing of menarche—that are less easy to interpret in the pres-
ent cross-sectional sample. Such observations appear to con-
trast with the reported higher AMH levels in women with
PCOS and their ﬁrst-degree relatives in childhood (19, 20).
PCOS is a condition closely related to excess weight gain
and hyperandrogenism. In the ALSPAC study we have
previously shown that DHEAS and androstenedione levels
are associated with low birthweight and accelerated
postnatal weight gain (22). However, we could not detect
any relationship between AMH levels and levels of these
androgens, nor with birthweight, in the 8-year-old girls.
The paradoxic ﬁndings of elevated AMH levels in obese
PCOS women yet reduced AMH levels in prepubertal girls
with higher BMI may reﬂect genetic/environmental
disturbances in the regulation of antral follicular
development in PCOS.
Indeed, the inﬂuence of sex steroids on circulating AMH
levels remains debated. Initial studies suggested that AMH
levels were stable, as they showed little intracycle variationVOL. 99 NO. 7 / JUNE 2013
Fertility and Sterility®and were not affected by administration of steroidal or gona-
datropic hormones (26, 27). However, recent studies have
reported that younger women show greater intraindividual
ﬂuctuations in AMH levels during the menstrual cycle (28).
Understanding the determinants of AMH levels requires
further experimental approaches as well as analyses of large
longitudinal cohort studies during childhood and
adolescence with measures of pubertal timing and sex
hormone levels.
In conclusion, complex changes in serum AMH and in-
hibin B levels in girls during the peripubertal years may reﬂect
changes in the rate of ovarian follicle recruitment and follicle
activity, respectively. The rise in AMH and inhibin B levels
during prepubertal childhood supports the intriguing concept
that increasing ovarian primordial follicle recruitment and
follicle activity precedes the onset of central puberty. The sub-
sequent divergence in AMH and inhibin B levels following the
onset of puberty may reﬂect the falling rate of primordial fol-
licle recruitment when FSH-stimulated follicle activity in-
creases. Despite these marked longitudinal changes, AMH
levels tracked strongly within individuals during the peripu-
bertal years.
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